tiprankstipranks
Trending News
More News >
People's Insurance Co (Group) of China Ltd Class H (HK:1339)
:1339

People's Insurance Co (Group) of China (1339) AI Stock Analysis

Compare
12 Followers

Top Page

HK:1339

People's Insurance Co (Group) of China

(1339)

Select Model
Select Model
Select Model
Outperform 78 (OpenAI - 4o)
Rating:78Outperform
Price Target:
HK$8.50
▲(24.09% Upside)
People's Insurance Co (Group) of China receives a strong overall score of 78, driven primarily by its robust financial performance and attractive valuation. The technical analysis supports a positive outlook, with bullish momentum and favorable price trends. While the financial health is solid, attention to liability management is advised.
Positive Factors
Revenue Growth
Strong revenue growth indicates robust demand for PICC's insurance products and effective market penetration, supporting long-term business expansion.
Profitability
Improved profitability reflects efficient cost management and operational performance, enhancing PICC's ability to reinvest in growth and innovation.
Cash Generation
Robust cash generation provides financial flexibility for PICC to invest in strategic initiatives, manage liabilities, and return capital to shareholders.
Negative Factors
High Total Liabilities
Elevated liabilities could strain PICC's financial resources and limit its ability to respond to economic changes or invest in growth opportunities.
Investing Cash Flow Fluctuations
Volatile investing cash flows may impact PICC's ability to consistently fund growth projects or manage its investment portfolio effectively.
Liability Management
Effective liability management is crucial for maintaining financial stability and ensuring PICC can meet its long-term obligations without compromising growth.

People's Insurance Co (Group) of China (1339) vs. iShares MSCI Hong Kong ETF (EWH)

People's Insurance Co (Group) of China Business Overview & Revenue Model

Company DescriptionThe People's Insurance Company (Group) of China Limited, an investment holding company, engages in the insurance business in the People's Republic of China. It operates through Non-Life Insurance, Life Insurance, Health Insurance, Asset Management, and Others segments. The company offers property and casualty insurance products, including motor vehicle, commercial property, liability, credit, accidental injury and health, cargo, agricultural, and other insurance products. It also provides life insurance products comprising general life and health insurance, participating life insurance, universal life insurance, and accident insurance; and health insurance products, such as medical, illness, nursing care, accidental injury, disability losses, and participating endowment insurance products. In addition, the company engages in asset management, insurance agent, and reinsurance business, as well as offers integrated financial products and services. The People's Insurance Company (Group) of China Limited was founded in 1949 and is based in Beijing, the People's Republic of China.
How the Company Makes MoneyPICC generates revenue primarily through its insurance premiums, which are collected from policyholders in exchange for coverage against various risks. The company offers a diverse array of insurance products, including property and casualty, life, and health insurance, each contributing to its premium income. Additionally, PICC earns revenue from investment income derived from the premiums it collects, as the company invests these funds in various financial instruments such as stocks, bonds, and real estate. Other significant revenue streams include reinsurance and asset management services. PICC's extensive distribution network and partnerships with banks, financial institutions, and other businesses further enhance its reach and ability to generate income, as these collaborations facilitate the sale of insurance products to a broader customer base.

People's Insurance Co (Group) of China Financial Statement Overview

Summary
People's Insurance Co (Group) of China demonstrates strong financial health with consistent revenue and profit growth. The income statement shows increasing profitability, the balance sheet reflects reduced leverage, and cash flow indicates strong cash generation. However, high total liabilities and fluctuations in investing cash flow pose potential risks.
Income Statement
85
Very Positive
The income statement demonstrates strong profitability with an increasing net profit margin from 4.5% in 2023 to 7.8% in 2024. The revenue growth rate is also impressive at 9.4% in 2024, indicating robust growth. EBIT and EBITDA margins have improved significantly, reflecting efficient cost management and operational performance.
Balance Sheet
80
Positive
The balance sheet is solid with a declining debt-to-equity ratio, reaching 0.19 in 2024, which signifies reduced financial leverage. The equity ratio is stable, and ROE has improved to 15.9% in 2024, showcasing effective use of shareholders' equity. However, the high total liabilities remain a potential risk.
Cash Flow
78
Positive
The cash flow statement shows a healthy operating cash flow, with a strong free cash flow growth of 24.8% in 2024. The operating cash flow to net income ratio is robust at 2.05, indicating strong cash generation relative to accounting earnings. However, fluctuations in investing cash flow could pose challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue576.06B598.79B530.21B475.09B592.01B579.07B
Gross Profit576.06B653.20B577.73B469.88B539.73B514.55B
EBITDA0.0077.48B42.07B52.85B45.90B41.75B
Net Income46.71B42.15B22.32B25.37B21.48B20.04B
Balance Sheet
Total Assets1.88T1.77T1.56T1.51T1.38T1.26T
Cash, Cash Equivalents and Short-Term Investments737.01B664.26B21.87B21.36B21.79B23.13B
Total Debt41.51B52.60B40.26B46.20B47.43B60.34B
Total Liabilities1.49T1.40T1.23T1.21T1.08T982.51B
Stockholders Equity285.11B268.73B242.35B221.77B219.26B202.48B
Cash Flow
Free Cash Flow88.51B83.59B66.98B65.08B110.35B59.83B
Operating Cash Flow92.79B87.99B70.55B71.65B72.73B31.87B
Investing Cash Flow-98.88B-77.60B-70.93B-73.28B-81.56B-51.37B
Financing Cash Flow12.05B4.86B-11.48B8.56B-35.86B21.11B

People's Insurance Co (Group) of China Technical Analysis

Technical Analysis Sentiment
Positive
Last Price6.85
Price Trends
50DMA
7.04
Negative
100DMA
6.78
Positive
200DMA
5.83
Positive
Market Momentum
MACD
-0.09
Negative
RSI
50.78
Neutral
STOCH
62.34
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:1339, the sentiment is Positive. The current price of 6.85 is above the 20-day moving average (MA) of 6.85, below the 50-day MA of 7.04, and above the 200-day MA of 5.83, indicating a neutral trend. The MACD of -0.09 indicates Negative momentum. The RSI at 50.78 is Neutral, neither overbought nor oversold. The STOCH value of 62.34 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:1339.

People's Insurance Co (Group) of China Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
83
Outperform
HK$220.28B5.2534.37%5.36%49.90%203.77%
78
Outperform
HK$418.91B6.2417.99%3.15%9.40%79.93%
76
Outperform
HK$370.56B9.0114.60%3.80%6.42%66.35%
76
Outperform
HK$409.24B6.0418.41%3.31%15.08%23.13%
71
Outperform
HK$68.50B8.3810.74%1.84%23.64%36.32%
71
Outperform
HK$156.30B11.299.41%3.86%51.04%24.56%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:1339
People's Insurance Co (Group) of China
6.91
3.34
93.67%
HK:2601
China Pacific Insurance (Group) Co
35.92
13.02
56.88%
HK:0966
China Taiping Insurance Holdings Co
19.06
7.68
67.49%
HK:2328
PICC Property & Casualty Co
16.50
4.95
42.83%
HK:6099
China Merchants Securities Co., Ltd. Class H
14.37
-0.88
-5.77%
HK:1336
New China Life Insurance Co., Ltd. Class H
54.40
32.59
149.43%

People's Insurance Co (Group) of China Corporate Events

People’s Insurance VP Under Investigation, Operations Unaffected
Dec 7, 2025

The People’s Insurance Company (Group) of China Limited announced that its Vice President, Mr. Yu Ze, is under investigation by the Central Commission for Discipline Inspection and the National Supervisory Commission for suspected serious violations of discipline and law. Despite the investigation, the company has stated that its management and operations remain unaffected.

PICC Focuses on Non-Auto Insurance Development at 2025 Investor Day
Nov 7, 2025

The People’s Insurance Company (Group) of China Limited held its 2025 Investor Open Day, emphasizing the theme of ‘Practices and Outlook for the High-Quality Development of Non-Auto Insurance.’ This event underscores the company’s strategic focus on enhancing its non-auto insurance offerings, which may impact its market positioning and stakeholder interests.

People’s Insurance Co of China Approves 2025 Interim Dividend
Oct 30, 2025

The People’s Insurance Company (Group) of China Limited announced the successful passing of resolutions at its 2025 second extraordinary general meeting, including the approval of the 2025 interim profit distribution. The interim dividend, amounting to RMB3.317 billion, will be distributed to shareholders in December 2025, reflecting the company’s strong financial performance and commitment to shareholder returns.

People’s Insurance Co of China Updates Interim Dividend Details
Oct 30, 2025

The People’s Insurance Company (Group) of China Limited announced an update to its interim cash dividend for the six months ended June 30, 2025. The dividend is set at RMB 0.075 per share, with a corresponding payment in Hong Kong dollars at an exchange rate of RMB 1 to HKD 1.09603214. The ex-dividend date is November 4, 2025, and the payment will be made on December 12, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may impact its financial positioning and investor relations positively.

People’s Insurance Co (Group) of China Reports Robust Q3 2025 Financial Growth
Oct 30, 2025

The People’s Insurance Company (Group) of China Limited reported significant financial growth in its third quarterly report of 2025, with a notable increase in both total operating income and net profit attributable to owners. The company’s total assets and equity have also seen substantial growth, indicating a strong financial position and positive market performance.

People’s Insurance Co. to Host Q3 2025 Results Announcement
Oct 27, 2025

The People’s Insurance Company (Group) of China Limited announced its plan to hold the 2025 Third Quarter Results Announcement through a text interaction session on October 31, 2025. This event will allow investors to engage with the company by submitting questions in advance, which will be addressed during the session, potentially impacting investor relations and market perceptions.

People’s Insurance Co (Group) of China Schedules Board Meeting for Q3 Results
Oct 16, 2025

The People’s Insurance Company (Group) of China Limited has announced a board meeting scheduled for October 30, 2025, to review and approve the unaudited third-quarter results for the period ending September 30, 2025. This meeting is significant as it will provide insights into the company’s financial performance and could impact its market positioning and stakeholder confidence.

People’s Insurance Co. Announces 2025 Second EGM
Oct 9, 2025

The People’s Insurance Company (Group) of China Limited has announced the scheduling of its 2025 second extraordinary general meeting (EGM) to be held on October 30, 2025. The meeting will address resolutions concerning the 2025 interim profit distribution and amendments to the authorization plan for the Board of Directors. This announcement is significant as it outlines key corporate governance actions that could impact shareholder value and company operations.

People’s Insurance Co. Announces Interim Dividend Update
Oct 9, 2025

The People’s Insurance Company (Group) of China Limited announced an update to its interim dividend for the six months ended 30 June 2025, declaring a dividend of RMB 0.075 per share. The update includes details on the date of shareholders’ approval, Hong Kong share register information, and withholding tax arrangements. This announcement is significant for stakeholders as it provides clarity on the financial returns and tax implications for both resident and non-resident shareholders, potentially impacting investor decisions and market perception.

People’s Insurance Co (Group) of China Announces Board and Committee Structure
Sep 30, 2025

The People’s Insurance Co (Group) of China has announced the composition of its board of directors and the establishment of five special committees under the board. This organizational structure aims to enhance the company’s strategic direction, risk management, and governance, potentially strengthening its position in the insurance industry and improving stakeholder confidence.

People’s Insurance Co. Appoints New Non-Executive Director
Sep 30, 2025

The People’s Insurance Company (Group) of China Limited has announced the appointment of Mr. Xu Xiang as a non-executive director, effective from September 29, 2025, following approval from the National Financial Regulatory Administration. This strategic appointment, which also includes Mr. Xu’s roles in the Risk Management & Consumers’ Rights and Interests Protection Committee and the Nomination and Remuneration Committee, is expected to enhance the company’s governance and oversight capabilities, potentially strengthening its market position and stakeholder confidence.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 23, 2025